Assogomma comments on the Annex XV Dossier of the universal PFAS restriction proposal September, 6th 2023 1 1.

Serveurs haute performance Comments on PFAS ECHA consultation.

Classification: Public Merck Healthcare KGaA 64293 Darmstadt Germany Additional Information on Missing Uses with regard to the ANNEX XV Restriction Report on Per- and polyfluoroalkyl substances (PFASs) as published by ECHA on March 22nd, 2023 Content Use Sector...................................................................................... 2 Information on Uses Covered in the Annex XV Report ............................ 2 EU Approved Active Pharmaceutical Ingredients ................................. 2 F-Gases....................................................................................... 2 Information on Uses Not Covered in the Annex XV Report (Missing Uses) . 2 Medicinal Products ........................................................................ 2 Fluoropolymers in Industrial Use ..................................................... 4 Starting Materials, Reagents, Intermediates, Solvents, Auxiliaries ......... 5 Active Pharmaceutical Ingredients in Development Products ................ 6 Immediate Packaging of Injectable Medicinal Products ........................ 7 Medical Devices ............................................................................ 8 Conclusion ................................................................................... 8 2 Merck Healthcare KGaA Classification: Public Use Sector Merck Healthcare KGaA is one of the three business sectors of Merck KGaA.

National PFAS Testing Strategy: Identification of Candidate Per- and Polyfluoroalkyl Substances (PFAS) for Testing October 2021 U.S.

RWG BY KAMAN Comment for PFAS Consultation on Restriction of Production, Marketing and Use of PFAS Prepared by: Lukas Will I Junior Application Engineer Date: September, 2023 Local Contact: Lukas Will +49 9193 50105 254 @Kaman.com RWG Germany GmbH Medbacher Weg 1 91315 Hochstadt a.d.

Apr 25, 2023 Comment on Proposed Restriction of PFAS Conference of Fluoro-Chemical Product Japan (FCJ) On behalf of chemical manufacturers, we, Conference of Fluoro-Chemical Product Japan (FCJ), have been working tirelessly to comply with national chemical regulations.

MPTB-ES-PO-0131 Paris, 22 September 2023 EUROPEAN SPACE SECTOR COMMENTS ON THE ANNEX XV RESTRICTION REPORT FOR PER- AND POLYFLUOROALKYL SUBSTANCES (PFAS) ECHA Public Consultation of 22 March 2023 on the proposed restriction on the manufacture, placing on the market and use of PFASs 0 MPTB-ES-PO-0131 PREFACE This is the joint contribution of the European Space Industry, represented by ASD-EUROSPACE - with the support of European Space Agency (ESA), national space agencies and the European Defence Agency (EDA)1 - to the ECHA Public Consultation on the Annex XV restriction report of 22 March 2023 for PFASs.

Response to the public consultation on the global PFAS restriction project September 2023 1 Five connector manufacturers - Amphenol Socapex, Eaton Souriau ITD, ITT Cannon GmbH, Radiall SA and TE Connectivity- have decided to call on EcoMundo as an independent third party to collect, aggregate and anonymise data for their response to the public consultation on the global PFAS restriction project.

iScience Cellpress OPEN ACCESS ArticIr Implications of PFAS definitions using fluorinated pharmaceuticals Organofluorine Pharmaceuticals (360) Fluoxetine (Prozac) Sitagliptin (Januvia) Atorvastatin (Lipitor) Ciprofloxacin (Cipro) Fluticasone Propionate (Flonase) Screening Against 9 PFAS Definitions Chemical Substructures F F F Emily Hammel, Thomas F.

Ionomr Innovations Inc. 2386 East Mall, Suite 111 Vancouver, BC V6T 1Z3 Canada Subject: Ionomr Innovations Inc. submission to public consultation 2023 September 23 Dear Members of the ECHA Review Committee, Thank you for taking PFAS seriously.

* * * * pneurop ** * * * FRANKFURT, 2023-09-04 Pneurop committee 5 "Vacuum technology" (PN 5) Draft position paper on the planned restriction of PFAS Version 2.1 Table of content 1.

ZeroPM Alternatives database: Contribution of Stockholm University to the public consultation on the restriction on uses of per- and polyfluoroalkyl substances (PFAS) Contents Background information .................................................................................................................. 2 1.

Transnational Environmental Law, 10:1 (2021), pp. 159-187 The Author(s), 2021.

Proposal for reporting data relevant for human health Human Health Assessment of Perfluoroalkyl carboxylic Acids (PFCAs) 25/10/2022 Current state of the assessment based on in vivo studies used in the EFSA Opinion (2020) and ATSDR Report (2018).

JIMA PFAS APPENDIX01 2023/09/14 Japan Inspection Instruments Manufacturer's Association (JIMA) Appendix 01 Uses and substitutions of Specialist Equipment This document is the appendix 01 of the general comment to the Restriction report on Per- and polyfluoroalkyl substances (PFAS) from Japan Inspection Instruments Manufacturers' Association (JIMA) submitted on 14.